Your browser doesn't support javascript.
loading
HDAC6 Interacts With Poly (GA) and Modulates its Accumulation in c9FTD/ALS.
Del Rosso, Giulia; Carlomagno, Yari; Todd, Tiffany W; Jones, Caroline Y; Prudencio, Mercedes; Daughrity, Lillian M; Yue, Mei; Jansen-West, Karen; Tong, Jimei; Shao, Wei; Wu, Yanwei; Castanedes-Casey, Monica; Tabassian, Lilia; Oskarsson, Björn; Ling, Karen; Rigo, Frank; Dickson, Dennis W; Yao, Tso-Pang; Petrucelli, Leonard; Cook, Casey N; Zhang, Yong Jie.
Afiliação
  • Del Rosso G; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, United States.
  • Carlomagno Y; Neuroscience Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, FL, United States.
  • Todd TW; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, United States.
  • Jones CY; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, United States.
  • Prudencio M; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, United States.
  • Daughrity LM; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, United States.
  • Yue M; Neuroscience Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, FL, United States.
  • Jansen-West K; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, United States.
  • Tong J; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, United States.
  • Shao W; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, United States.
  • Wu Y; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, United States.
  • Castanedes-Casey M; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, United States.
  • Tabassian L; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, United States.
  • Oskarsson B; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, United States.
  • Ling K; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, United States.
  • Rigo F; Department of Neurology, Mayo Clinic, Jacksonville, FL, United States.
  • Dickson DW; Ionis Pharmaceuticals, Carlsbad, CA, United States.
  • Yao TP; Ionis Pharmaceuticals, Carlsbad, CA, United States.
  • Petrucelli L; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, United States.
  • Cook CN; Neuroscience Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, FL, United States.
  • Zhang YJ; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, United States.
Front Cell Dev Biol ; 9: 809942, 2021.
Article em En | MEDLINE | ID: mdl-35096836
ABSTRACT
The aberrant translation of a repeat expansion in chromosome 9 open reading frame 72 (C9orf72), the most common cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), results in the accumulation of toxic dipeptide repeat (DPR) proteins in the central nervous system We have found that, among the sense DPR proteins, HDAC6 specifically interacts with the poly (GA) and co-localizes with inclusions in both patient tissue and a mouse model of this disease (c9FTD/ALS). Overexpression of HDAC6 increased poly (GA) levels in cultured cells independently of HDAC6 deacetylase activity, suggesting that HDAC6 can modulate poly (GA) pathology through a mechanism that depends upon their physical interaction. Moreover, decreasing HDAC6 expression by stereotaxic injection of antisense oligonucleotides significantly reduced the number of poly (GA) inclusions in c9FTD/ALS mice. These findings suggest that pharmacologically reducing HDAC6 levels could be of therapeutic value in c9FTD/ALS.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Cell Dev Biol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Cell Dev Biol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos